Sierra Oncology surges 50%, here is the catalyst

Sierra Oncology Inc. (NASDAQ: SRRA) shares are up 50% after the company announced a term loan deal with Oxford Finance LLC and the release of positive topline results from the vital Phase III MOMENTUM study. The MOMENTUM study, a global double-blind, randomized trial, evaluated momelotinib in treating patients with myelofibrosis that are anemic and symptomatic […]

La notizia Sierra Oncology surges 50%, here is the catalyst era stato segnalata su Invezz.